Decoding Trump 2.0: The Global Ripple Effect on Biotech and Medtech in Asia
📣 Join Us for a Timely Industry Dialogue
As sweeping policy shifts unfold under the second Trump administration, Asia’s biotech and medtech sectors are facing a new wave of geopolitical and regulatory uncertainty. How will these developments impact innovation, market expansion, and compliance across the region? And how can Asia-based companies future-proof their go-to-market strategies in an increasingly volatile global landscape?
Biotech Connection Singapore (BCS), in collaboration with Asia Pacific Medical Technology Association (APACMed) and Geneo at Singapore Science Park, is proud to present a panel discussion and networking event exploring these critical questions.
Decoding Trump 2.0: The Global Ripple Effect on Biotech and Medtech in Asia
🗓 Date: Tuesday, 20 May 2025
🕔 Time: 5:00 – 8:00 PM
📍 Venue: Metro @ Bridge+, 2 Science Park Drive, Ascent, Level 1, Singapore 118222
🎤 Opening Speaker & Panel Moderator:
Sejal Mistry – Director, Crowell Global Advisors
💡 Panel Speakers:
Stephen Lim – CEO, FathomX
Vishal Doshi – Founder & CEO, AUM Biosciences
Michael Ma – CEO, MedAsian Health Technology Co. Ltd
🤝 Don’t miss this opportunity to connect with industry leaders and explore how Asia’s biotech and medtech players are adapting and thriving in a rapidly evolving global landscape.
🔗 Register here: https://lu.ma/iayto5i2
#Biotech #Medtech #HealthcareInnovation #Asia #BioMedtech #GlobalHealthPolicy #BCS #APACMed #Geneo #SingaporeSciencePark #SSP #Geopolitics #FDA #AIinHealthcare #Trump